H. Lundbeck A/S: Alzheimer Disease trials
The registry lists 17 Alzheimer Disease studies with H. Lundbeck A/S as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 6Phase 2 2Phase 3 6Phase 4 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With AlzheimerCompletedNCT02553928Phase 4Results posted
- Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseCompletedNCT02079246Phase 3Results posted
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorCompletedNCT02006654Phase 3Results posted
- Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilCompletedNCT02006641Phase 3Results posted
- Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With DonepezilCompletedNCT01955161Phase 3Results posted
- A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's DiseaseCompletedNCT00862940Phase 4Results posted
- Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's DiseaseTerminatedNCT00857649Phase 3Results posted
- Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's DiseaseTerminatedNCT00857233Phase 3Results posted
- Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's DiseaseCompletedNCT04149860Phase 1
- Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to ADTerminatedNCT03819699Phase 1
- A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)TerminatedNCT03668405Phase 1
- Positron Emission Tomography (PET) Study in Patients With Alzheimer's DiseaseTerminatedNCT03307993Phase 1
- Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's DiseaseTerminatedNCT02388152Phase 1
- Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney FunctionCompletedNCT02340195Phase 1
- Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's DiseaseCompletedNCT01019421Phase 2
- Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT00855686Phase 4
- SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00093951Phase 2